15-HYDROXYPROSTAGLANDIN DEHYDROGENASE (NAD(+))
UNII 8A6LTM0RO3

Substance Identification & Data

This profile provides standardized clinical and technical data for 15-hydroxyprostaglandin Dehydrogenase (nad(+)), uniquely identified by the FDA Unique Ingredient Identifier (UNII) 8A6LTM0RO3.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
8A6LTM0RO3
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
15-HYDROXYPROSTAGLANDIN DEHYDROGENASE (NAD(+))
Official standardized name for this substance within the FDA UNII nomenclature system.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for 15-hydroxyprostaglandin Dehydrogenase (nad(+)). Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

15-HYDROXYPROSTAGLANDIN DEHYDROGENASE (NAD(+))
15-PGDH
PGDH1
PROSTAGLANDIN DEHYDROGENASE 1
SDR36C1
SHORT CHAIN DEHYDROGENASE/REDUCTASE FAMILY 36C MEMBER 1

External Clinical & Regulatory Resources

NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record